From Phase III Trials to Commercialization Partnerships, MindRank’s AI Drug Development Value Comes into Focus
TMX Group Equity Financing Statistics – September 2026
TMX Group Limited Announces Release Date for Q3 2026 Financial Results and Analyst Conference Call
GMG Announces 48% Increase in Energy Density, Doubling of Cycle Life and 94% Energy Efficiency for 6 Minute Fast Charge
DGTL Holdings Inc. Announces Failure-to-File Cease Trade Order
– Results from analysis of three Phase 3 clinical studies showed statistically significant improvement in…
Additional data from SIGNAL Huntington’s disease (HD) trial support continued development in HD and in…
– PEDFIC 1 meets both U.S. and EU primary and secondary endpoints with highly statistically…
–Single and multiple intravitreal injections of NGM621 appeared safe and well tolerated in first-in-human study,…
– Findings support upcoming launch of T-Detect™ COVID, first T-cell test for novel coronavirus– Data…
Phesgo offers faster and less invasive delivery of standard of care treatment with Perjeta and…
First report of pathological role for microglial calcium activity in cortical spreading depolarization (CSD), a…
– Data show longer-term, differentiated safety profile of vebicorvir and the importance of HBV pregenomic…
U.S. Food and Drug Administration (FDA) clearance of PMV Pharmaceutical’s investigational new drug application for…
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:…
Mountain View, CA, Nov. 13, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Aditx Therapeutics, Inc….
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS),…
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT),…
BALA CYNWYD, Pa., Nov. 13, 2020 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
– Data demonstrated compelling efficacy profile and favorable tolerability with weekly and every two-week dosing…
SAN FRANCISCO, Nov. 13, 2020 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) and affiliate…
Company Management and Principal Investigator of ReSPECT to Discuss Interim Data Webinar Scheduled for Thursday,…
OCALA, Fla., Nov. 13, 2020 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM), an…
CAMBRIDGE, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company…
SAN DIEGO, Nov. 13, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company…